Single Pass Albumin Dialysis in Patients With Cirrhosis

Prospective Pilot Study Assessing Safety and Efficacy of Single Pass Albumin Dialysis in Patients With Acute on Chronic Liver Failure

The aim of this study is to determine whether a simplified device of albumin dialysis also has beneficial effects.

Albumin dialysis has beneficial effects in patients with acute on chronic liver failure. However, current devices are complex and costly. The aim of this study is to determine whether a simplified device of albumin dialysis also has beneficial effects.

Inclusion Criteria:

• Minimum age of 18 years
• Written consent after information of the patient or, in case of inability, by a parent or a close if he is present.
• Patient having a cirrhosis researched by previous exams (liver biopsy) or, in the absence of previous diagnosis, diagnosed in view of the results of clinical, biological and morphological data, whatever the origin of the cirrhosis (virus of hepatitis B, virus of hepatitis C, extreme consumption of alcohol or other reasons)

Exclusion Criteria:

• Participation to an other study in the 4 weeks before
• Active digestive bleeding, unchecked by the pharmacological treatments and the endoscopic techniques.